SCHEMBL7567323

SCHEMBL7567323

CCN(CC)C(=N)c1nccnc1-c1ccc(N)cc1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ PSMD14 O00487 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ GFER P55789 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ PDE3B Q13370 1/20 0.32
▸ PDE3A Q14432 1/20 0.32
▸ PRKCI P41743 1/20 0.31
▸ JAK2 O60674 1/20 0.31
▸ JAK3 P52333 1/20 0.31
▸ ACHE P22303 1/20 0.30
▸ CYP19A1 P11511 1/20 0.30
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7565847 0.86 MAPT (0.37) LMNASMN1; SMN2ALDH1A1CYP3A4MAPT
SCHEMBL7571240 0.83 PDE3B (0.34) SMN1; SMN2ALDH1A1CYP3A4MAPK1TDP1
Hydrochloric Acid SCHEMBL7566886 0.82 PDE3B (0.33) SMN1; SMN2ALDH1A1CYP3A4TDP1PDE3B
SCHEMBL7567678 0.79 PDE3B (0.32) PDE3BPDE3A
SCHEMBL7567254 0.76 PLAU (0.42) SMN1; SMN2ALDH1A1CYP3A4MAPK1TDP1
Hydrochloric Acid SCHEMBL7566216 0.74 F2 (0.44) SMN1; SMN2ALDH1A1CYP3A4MAPK1TDP1
Hydrochloric Acid SCHEMBL7565620 0.74 F2 (0.44) SMN1; SMN2ALDH1A1CYP3A4MAPK1TDP1
SCHEMBL22270622 0.70 ALDH1A1 (0.46) LMNASMN1; SMN2PSMD14ALDH1A1CYP3A4
SCHEMBL10726634 0.69 ALDH1A1 (0.53) LMNASMN1; SMN2ALDH1A1CYP3A4TSHR
SCHEMBL14134218 0.69 HCRTR1 (0.44) LMNASMN1; SMN2ALDH1A1MAPK1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492502-B2 REDUCTION OF A QUATERNARY AMMONIUM CONTAINING NITRO COMPOUND, TO FORM AN INTERMEDIATE, OXIDIZING TO GIVE AZO COMPOUND; USEFUL FOR DYEING HAIR L'OREAL, S.A. (FR) 2002-12-10 — — US claimed
US-20020165368-A1 Novel azo compounds, use in dyeing, compositions containing them and dyeing processes L'OREAL S.A. 2002-11-07 — — US claimed
US-20010001332-A1 Novel azo compounds, use in dyeing, compositions containing them and dyeing processes L'OREAL S.A. 2001-05-24 — — US claimed
US-6492502-B2 REDUCTION OF A QUATERNARY AMMONIUM CONTAINING NITRO COMPOUND, TO FORM AN INTERMEDIATE, OXIDIZING TO GIVE AZO COMPOUND; USEFUL FOR DYEING HAIR L'OREAL, S.A. (FR) 2002-12-10 — — US disclosed
US-20020165368-A1 Novel azo compounds, use in dyeing, compositions containing them and dyeing processes L'OREAL S.A. 2002-11-07 — — US disclosed
US-6179881-B1 USING (DIAZINE OR HYDRAZINE)CARBOXIMIDAMIDE COMPOUNDS L'OREAL (FR) 2001-01-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010001332-A1 Novel azo compounds, use in dyeing, compositions containing them and dyeing processes KRT18, MKI67, KDM5A LMNA 497/4885SMN1; SMN2 4705/4885PSMD14 1054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback